Search Results for "effective probing techniques"

Michael Pietrack

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Feb 19^th • 6 mins read

Michael Pietrack

Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Aug 20^th • 6 mins read

Tom Caravela

Interview Differentiator-Be a Story Teller

Mar 22^nd • 1 min read

Tom Caravela

12 Interview Techniques to Help Land Your Next Job

May 12^th • 1 min read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

May 19^th • 2 mins read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Tom Caravela

INTENTION: The Key to Achieving Your Goals

Jan 21^st • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3^rd • 1 min read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Apr 7^th • 12 mins read

Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23^rd • 8 mins read

Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11^th • 4 mins read

Paulo J. Oliveira, Ana M. Urbano

“Oncometabolism: The switchboard of cancer: An editorial”

Feb 1^st • 1 min read

Daan Geert Knapen, Nathan I. Cherny, Panagiota Zygoura, Nicola Jane Latino, Jean-Yves Douillard, Urania Dafni, Elisabeth G.E. de Vries, Derk Jan de Groot

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

Sep 6^th • 17 mins read

Fei Liang, Sheng Zhang, Qin Wang, Wenfeng Li

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Aug 31^st • 16 mins read

Cornelius F Waller & Adriano Friganovi´c

Biosimilars in oncology: key role of nurses in patient education

Jun 15^th • 10 mins read

Navigation

Results for 'effective probing techniques'

Leadership Lab: Take a Cue From Athletes by Working With an Executive Coach

Leadership Lab: 4 Ways Biopharma Leaders Can Prepare for Media Interviews

Interview Differentiator-Be a Story Teller

12 Interview Techniques to Help Land Your Next Job

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

Resume Writing and Editing Tips for Pharma Professionals

INTENTION: The Key to Achieving Your Goals

MSL People Skills: Top 10 Tips for Better Engagement

Promotability: How to Land Your Next Promotion

Positioning Yourself to Become an MSL in 2022

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Transforming oncology: Five frontiers driving progress in cancer care

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

“Oncometabolism: The switchboard of cancer: An editorial”

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

Biosimilars in oncology: key role of nurses in patient education

Related Topics